SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Panacea Biotec board to consider dividend

27 Apr 2012 Evaluate

Panacea Biotec has informed that a meeting of the board of directors of the company will be held on May 18, 2012, to consider and approve the audited financial results for the financial Year 2010-11 and also to consider the matter pertaining to recommendation / passing over of dividend.

The above information is part of company’s filing submitted to the BSE.

Panacea Biotec Share Price

342.05 -15.95 (-4.46%)
20-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×